Viewing Study NCT06411002


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-02-24 @ 7:15 PM
Study NCT ID: NCT06411002
Status: COMPLETED
Last Update Posted: 2025-04-04
First Post: 2024-05-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines
Sponsor: Revance Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module